
    
      Attention-Deficit/Hyperactivity Disorder (ADHD) is a psychiatric disorder characterized by 3
      main symptoms: inattention, hyperactivity and impulsivity. This study will assess the safety
      and tolerability of SPD485 while attempting to establish the appropriate starting dose for
      subjects previously on an existing long-acting methylphenidate product.
    
  